For: | Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A. Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis. World J Gastroenterol 2018; 24(1): 139-149 [PMID: 29358890 DOI: 10.3748/wjg.v24.i1.139] |
---|---|
URL: | https://www.wjgnet.com/1009-3079/full/v24/i1/139.htm |
编号 | Citing Articles |
1 |
György Miklós Buzás, Péter Birinyi. Newer, Older, and Alternative Agents for the Eradication of Helicobacter pylori Infection: A Narrative Review. Antibiotics 2023; 12(6): 946 doi: 10.3390/antibiotics12060946
|
2 |
Guzel ISAEVA, Regina ISAEVA. Probiotics in the treatment of Helicobacter pylori infection: reality and perspective. Minerva Gastroenterology 2022; 68(3) doi: 10.23736/S2724-5985.21.02926-0
|
3 |
Cristian Gutiérrez-Zamorano, Marisela González-Ávila, Gustavo Díaz-Blas, Carlos T. Smith, Carlos González-Correa, Apolinaria García-Cancino. Increased anti-Helicobacter pylori effect of the probiotic Lactobacillus fermentum UCO-979C strain encapsulated in carrageenan evaluated in gastric simulations under fasting conditions. Food Research International 2019; 121: 812 doi: 10.1016/j.foodres.2018.12.064
|
4 |
Jian Zhang, Jingzhi Guo, Dan Li, Min Chen, Jie Liu, Chenchen Feng, Qi He, Jing Zhao, Luyao Zhang, Jie Chen, Yongquan Shi. The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment. Medicine 2020; 99(45): e22976 doi: 10.1097/MD.0000000000022976
|
5 |
Guzel Sh. Isaeva, R.A. Isaeva. Mechanisms of microbial interactions between probiotic microorganisms
and Helicobacter pylori. Clinical Microbiology and Antimicrobial Chemotherapy 2023; 25(3): 225 doi: 10.36488/cmac.2023.3.225-238
|
6 |
Neil R. O'Morain, Maria P. Dore, Anthony J. P. O'Connor, Javier P. Gisbert, Colm A. O'Morain. Treatment of Helicobacter pylori infection in 2018. Helicobacter 2018; 23(S1) doi: 10.1111/hel.12519
|
7 |
Giuseppe Losurdo, Ilaria Lacavalla, Francesco Russo, Giuseppe Riezzo, Irene Brescia, Maria Rendina, Enzo Ierardi, Alfredo Di Leo. Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy. Antibiotics 2022; 11(1): 78 doi: 10.3390/antibiotics11010078
|
8 |
Mārcis Leja, Uga Dumpis. What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?. Digestive Diseases and Sciences 2020; 65(6): 1632 doi: 10.1007/s10620-019-05893-z
|
9 |
Parisa Abedi Elkhichi, Masoumeh Aslanimehr, Adeleh Atar. A SYSTEMATIC REVIEW OF THE TREATMENT OF HELICOBACTER PYLORI BY THE EFFECT OF PROBIOTICS IN ASIAN POPULATION. Studies in Medical Sciences 2023; 34(3): 116 doi: 10.61186/umj.34.3.116
|
10 |
Jaime Ramirez, Francisco Guarner, Luis Bustos Fernandez, Aldo Maruy, Vera Lucia Sdepanian, Henry Cohen. Antibiotics as Major Disruptors of Gut Microbiota. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.572912
|
11 |
Natalia V Baryshnikova, Anastasia S Ilina, Elena I Ermolenko, Yury P Uspenskiy, Alexander N Suvorov. Probiotics and autoprobiotics for treatment of <i>Helicobacter pylori</i> infection. World Journal of Clinical Cases 2023; 11(20): 4740-4751 doi: 10.12998/wjcc.v11.i20.4740
|
12 |
Ying-ying Yu, Ling-yan Wu, Xue Sun, Qing Gu, Qing-qing Zhou. Effect of Lactobacillus plantarum ZFM4 in Helicobacter pylori-infected C57BL/6 mice: prevention is better than cure. Frontiers in Cellular and Infection Microbiology 2024; 13 doi: 10.3389/fcimb.2023.1320819
|
13 |
Qian Luo, Na Liu, Sugui Pu, Ze Zhuang, Hang Gong, Dekui Zhang. A review on the research progress on non-pharmacological therapy of Helicobacter pylori. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1134254
|
14 |
Sai Sri Penumetcha, Saher Ahluwalia, Rejja Irfan, Sawleha Arshi Khan, Sai Rohit Reddy, Maria Elisa Vasquez Lopez, Maryam Zahid, Alberto Busmail, Lubna Mohammed. The Efficacy of Probiotics in the Management of Helicobacter Pylori: A Systematic Review. Cureus 2021; doi: 10.7759/cureus.20483
|
15 |
Vanita Mulay, Dhanashri Satav, Austin Fernandes, Priyanka Pisalwar, Shadab Ahmed. Recent Trends and The Future of Antimicrobial Agents - Part I. 2023; : 140 doi: 10.2174/9789815079609123010008
|
16 |
Kun Xue, Yuwei Liu, Kia Nøhr Iversen, Mohsen Mazidi, Zheng Qu, Chenglin Dong, Tayi Jin, Göran Hallmans, Per Åman, Anders Johansson, Gengsheng He, Rikard Landberg. Impact of a Fermented High-Fiber Rye Diet on Helicobacter pylori and Cardio-Metabolic Risk Factors: A Randomized Controlled Trial Among Helicobacter pylori-Positive Chinese Adults. Frontiers in Nutrition 2021; 7 doi: 10.3389/fnut.2020.608623
|
17 |
Enzo Ierardi, Giuseppe Losurdo, Rosa Federica La Fortezza, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo. Optimizing proton pump inhibitors in <i>Helicobacter pylori</i> treatment: Old and new tricks to improve effectiveness. World Journal of Gastroenterology 2019; 25(34): 5097-5104 doi: 10.3748/wjg.v25.i34.5097
|
18 |
Valeria Garcia-Castillo, Ana María Marín-Vega, Alejandra Ilabaca, Leonardo Albarracín, Guillermo Marcial, Haruki Kitazawa, Apolinaria Garcia-Cancino, Julio Villena. Characterization of the immunomodulatory and anti-Helicobacter pylori properties of the human gastric isolate Lactobacillus rhamnosus UCO-25A. Biofouling 2019; 35(8): 922 doi: 10.1080/08927014.2019.1675153
|
19 |
Jyh-Ming Liou, Po-Yueh Chen, Yu-Ting Kuo, Ming-Shiang Wu. Toward population specific and personalized treatment of Helicobacter pylori infection. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0471-z
|
20 |
Masoud Keikha, Mohsen Karbalaei. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01977-1
|
21 |
Lorena Elena Meliț, Cristina Oana Mărginean, Maria Oana Săsăran. The Challenges of Eradicating Pediatric Helicobacter pylori Infection in the Era of Probiotics. Children 2022; 9(6): 795 doi: 10.3390/children9060795
|
22 |
José Antonio García-Santos, Ana Nieto-Ruiz, María García-Ricobaraza, Tomás Cerdó, Cristina Campoy. Impact of Probiotics on the Prevention and Treatment of Gastrointestinal Diseases in the Pediatric Population. International Journal of Molecular Sciences 2023; 24(11): 9427 doi: 10.3390/ijms24119427
|
23 |
Lina Elsalem, Ahmad A Jum'ah, Mahmoud A Alfaqih, Osama Aloudat. <p>The Bacterial Microbiota of Gastrointestinal Cancers: Role in Cancer Pathogenesis and Therapeutic Perspectives</p>. Clinical and Experimental Gastroenterology 2020; : 151 doi: 10.2147/CEG.S243337
|
24 |
Ali Nabavi-Rad, Shaghayegh Jamshidizadeh, Mahsa Azizi, Abbas Yadegar, Karen Robinson, Tanya M. Monaghan, Mohammad Reza Zali. The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1171469
|
25 |
M. R Konorev, S. V Guryanova, E. N Tyshevich, R. A Pavlyukov, O. Yu Borisova. Advisable including glucosaminylmuramyldipeptide in Helicobacter pylori therapy: experience of ten-year investigation. RUDN Journal of Medicine 2020; 24(3): 269 doi: 10.22363/2313-0245-2020-24-3-269-282
|
26 |
Federica Mascaretti, Salman Haider, Chiara Amoroso, Flavio Caprioli, Daryl Ramai, Michele Ghidini. Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers. Journal of Gastrointestinal Cancer 2024; 55(2): 662 doi: 10.1007/s12029-024-01021-x
|
27 |
Majid T. Moghadam, Zahra Chegini, Amin Norouzi, Amin S. Dousari, Aref Shariati. Three-Decade Failure to the Eradication of Refractory Helicobacter pylori Infection and Recent Efforts to Eradicate the Infection. Current Pharmaceutical Biotechnology 2021; 22(7): 945 doi: 10.2174/1389201021666200807110849
|
28 |
Shigeru Kamiya, Hideo Yonezawa, Takako Osaki. Helicobacter pylori in Human Diseases. Advances in Experimental Medicine and Biology 2019; 1149: 243 doi: 10.1007/5584_2019_369
|
29 |
Ferit ÇELİK, Ali ŞENKAYA. Evaluation of the efficacy of two different Helicobacter pylori eradication regimens at a secondary public health care center. Turkish Journal of Health Science and Life 2023; 6(1): 32 doi: 10.56150/tjhsl.1246441
|
30 |
Albert A. Rizvanov, Amin Talebi Bezmin Abadi. Helicobacter pylori Infection and Vaccination: Current Standoff. BioNanoScience 2019; 9(4): 928 doi: 10.1007/s12668-019-00637-9
|
31 |
Saurav Kumar Jha, Sumant Pandey, Ambikesh Karn, Vijay Kumar Panthi. Synbiotics for the Management of Cancer. 2023; : 305 doi: 10.1007/978-981-19-7550-9_15
|
32 |
Salvatore E. ARAGONA, Carlo FABBRI, Giovanni CAMMAROTA, Giorgio CIPRANDI. Probiotic mixture in patients after Helicobacter pylori eradication: a real-life experience. Minerva Gastroenterology 2024; 70(2) doi: 10.23736/S2724-5985.24.03634-9
|
33 |
Erick A. Argueta, Steven F. Moss. Treatment of Helicobacter pylori. Current Opinion in Gastroenterology 2019; 35(6): 544 doi: 10.1097/MOG.0000000000000578
|
34 |
Nermin Kamal Saeed, Mohammed Al-Beltagi, Adel Salah Bediwy, Yasser El-Sawaf, Osama Toema. Gut microbiota in various childhood disorders: Implication and indications. World Journal of Gastroenterology 2022; 28(18): 1875-1901 doi: 10.3748/wjg.v28.i18.1875
|
35 |
Diego Cabral Lacerda, Paulo César Trindade da Costa, Luciana Caroline Paulino do Nascimento, José Luiz de Brito Alves. Probiotics for Human Nutrition in Health and Disease. 2022; : 431 doi: 10.1016/B978-0-323-89908-6.00022-4
|
36 |
Ankita Saxena, Asish Kumar Mukhopadhyay, Shoma Paul Nandi. Helicobacter pylori: Perturbation and restoration of gut microbiome. Journal of Biosciences 2020; 45(1) doi: 10.1007/s12038-020-00078-7
|
37 |
E. Ng, J.R.H. Tay, M.M.A. Ong, N. Bostanci, G.N. Belibasakis, C.J. Seneviratne. Probiotic therapy for periodontal and peri-implant health – silver bullet or sham?. Beneficial Microbes 2021; 12(3): 215 doi: 10.3920/BM2020.0182
|
38 |
Ziying Yuan, Shiyu Xiao, Sizhu Li, Baojun Suo, Ye Wang, Lingmei Meng, Zuojing Liu, Zhihao Yin, Yan Xue, Liya Zhou. The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults. Helicobacter 2021; 26(6) doi: 10.1111/hel.12848
|
39 |
V. Т. Ivashkin, A. I. Ulyanin, I. V. Mayev, R. S. Kozlov, M. A. Livzan, S. R. Abdulkhakov, O. P. Alekseyeva, S. A. Alekseyenko, D. S. Bordin, N. N. Dekhnich, N. V. Korochyanskaya, T. L. Lapina, E. A. Poluektova, V. I. Simanenkov, A. S. Trukhmanov, I. B. Khlynov, V. V. Tsukanov, A. A. Sheptulin. Modern Approaches to <i>H. pylori</i> Eradication Therapy in Adults (Literature Review and Resolution of Experts Council). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(6): 7 doi: 10.22416/1382-4376-2022-32-6-7-19
|
40 |
Mei‐Jyh Chen, Chieh‐Chang Chen, Yu‐Chun Huang, Chieh‐Chih Tseng, Jing‐Ting Hsu, Yi‐Fen Lin, Yu‐Jen Fang, Ming‐Shiang Wu, Jyh‐Ming Liou. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double‐blind, placebo‐controlled, randomized trial. Helicobacter 2021; 26(6) doi: 10.1111/hel.12857
|
41 |
Debora Compare, Costantino Sgamato, Olga Maria Nardone, Alba Rocco, Pietro Coccoli, Carmen Laurenza, Gerardo Nardone. Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold. Digestive Diseases 2022; 40(1): 123 doi: 10.1159/000516023
|
42 |
Fanglei Zuo, Tanvi Somiah, Hanna G. Gebremariam, Ann-Beth Jonsson. Lactobacilli Downregulate Transcription Factors in Helicobacter pylori That Affect Motility, Acid Tolerance and Antimicrobial Peptide Survival. International Journal of Molecular Sciences 2022; 23(24): 15451 doi: 10.3390/ijms232415451
|
43 |
Xiaofen Bai, Minjie Zhu, Yajun He, Tengyan Wang, Da Tian, Jianchang Shu. The impacts of probiotics in eradication therapy of Helicobacter pylori. Archives of Microbiology 2022; 204(12) doi: 10.1007/s00203-022-03314-w
|
44 |
Toru Hiyama, Masaki Kunihiro, Naoki Asayama, Yuji Urabe, Hideharu Okanobu, Seiji Onogawa, Kayoko Kunihiro, Toshio Kuwai, Michiyo Kodama, Yoji Sanomura, Kenta Nagai, Hiroshige Hamada, Akira Furudoi, Tomohiro Miwata, Ritsuo Mouri, Kyoko Yoshioka, Shinji Tanaka, Shiro Oka. Hiroshima University Affiliated Hospital Probiotics Usage Guidelines. Nippon Daicho Komonbyo Gakkai Zasshi 2023; 76(7): 467 doi: 10.3862/jcoloproctology.76.467
|
45 |
Daoyan Wu, Mei Cao, Jie Zhou, Shiying Yan, Jingshan Peng, Zhihao Yu, Andong Zhang, Jialin Wu, Xin Yan, Jian Zhao. Lactobacillus casei T1 from kurut against Helicobacter pylori-induced inflammation and the gut microbial disorder. Journal of Functional Foods 2021; 85: 104611 doi: 10.1016/j.jff.2021.104611
|
46 |
Giuseppe LOSURDO, Federica FRANCIOSO, Maria PRICCI, Bruna GIRARDI, Francesco RUSSO, Giuseppe RIEZZO, Benedetta D’ATTOMA, Maria A. BLEVE, Andrea IANNONE, Francesca CELIBERTO, Enzo IERARDI, Alfredo DI LEO. A prospective study on Helicobacter pylori rapid urease test false negativity: is it time for its use in restricted situations?. Minerva Gastroenterology 2023; 69(3) doi: 10.23736/S2724-5985.22.03207-7
|
47 |
Taif Shah, Zulqarnain Baloch, Zahir Shah, Xiuming Cui, Xueshan Xia. The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases. International Journal of Molecular Sciences 2021; 22(12): 6597 doi: 10.3390/ijms22126597
|
48 |
Neda Shadvar, Sousan Akrami, Seyyed-Mohammad-Amin Mousavi Sagharchi, Rafee Habib Askandar, Alireza Merati, Masoomeh Aghayari, Nikki Kaviani, Hamed Afkhami, Mojtaba Kashfi. A review for non-antibiotic treatment of Helicobacter pylori: new insight. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1379209
|
49 |
Yu‐Zhen Wang, Jie Chen, Shi‐Qin Pei, Chen Wang, Gang Han, Lian‐Di Kan, Liu‐Cheng Li. Treatment strategies and pharmacist‐led medication management for Helicobacter pylori infection. Drug Development Research 2023; 84(2): 326 doi: 10.1002/ddr.22025
|
50 |
Meiyi Zhang, Chengcheng Zhang, Jianxin Zhao, Hao Zhang, Qixiao Zhai, Wei Chen. Meta-analysis of the efficacy of probiotic-supplemented therapy on the eradication of H. pylori and incidence of therapy-associated side effects. Microbial Pathogenesis 2020; 147: 104403 doi: 10.1016/j.micpath.2020.104403
|
51 |
Chuzi Mo, Jiaming Bi, Siwei Li, Yunhe Lin, Peiyan Yuan, Zhongjun Liu, Bo Jia, Shuaimei Xu. The influence and therapeutic effect of microbiota in systemic lupus erythematosus. Microbiological Research 2024; 281: 127613 doi: 10.1016/j.micres.2024.127613
|
52 |
Samaneh Soleymani, Farnaz Ebrahimi, Hossein Rezaeizadeh, Roja Rahimi. Nutraceuticals and Cancer Signaling. Food Bioactive Ingredients 2021; : 467 doi: 10.1007/978-3-030-74035-1_18
|
53 |
Chengting Chang, Xingzhu Yuan, Xingxia Zhang, Xinrong Chen, Ka Li. Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review. Nutrients 2022; 14(18): 3726 doi: 10.3390/nu14183726
|
54 |
Osamu Handa, Yuji Naito, Motoyasu Osawa, Takahisa Murao, Hiroshi Matsumoto, Eiji Umegaki, Akiko Shiotani. Nutrients and probiotics: current trends in their use to eradicate <i>Helicobacter pylori</i>. Journal of Clinical Biochemistry and Nutrition 2020; 67(1): 26 doi: 10.3164/jcbn.20-51
|
55 |
Paweł Krzyżek, Emil Paluch, Grażyna Gościniak. Synergistic Therapies as a Promising Option for the Treatment of Antibiotic-Resistant Helicobacter pylori. Antibiotics 2020; 9(10): 658 doi: 10.3390/antibiotics9100658
|
56 |
Paula Roszczenko-Jasińska, Marta Ilona Wojtyś, Elżbieta K. Jagusztyn-Krynicka. Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets. Applied Microbiology and Biotechnology 2020; 104(23): 9891 doi: 10.1007/s00253-020-10945-w
|
57 |
Xiaoguang Shi, Junhong Zhang, Lingshan Mo, Jialing Shi, Mengbin Qin, Xue Huang. Efficacy and safety of probiotics in eradicating Helicobacter pylori. Medicine 2019; 98(15): e15180 doi: 10.1097/MD.0000000000015180
|
58 |
Luisa F. Duque-Buitrago, Antonio Tornero-Martínez, Verónica Loera-Castañeda, Rosalva Mora-Escobedo. Use of food and food-derived products in the treatment of gastritis: A systematic review. Critical Reviews in Food Science and Nutrition 2023; 63(22): 5771 doi: 10.1080/10408398.2021.2024131
|
59 |
Andrea Mestre, Rajalakshmi Sathiya Narayanan, Deliana Rivas, Jobby John, Mohammed Ali Abdulqader, Tushar Khanna, Raja Chandra Chakinala, Sachin Gupta. Role of Probiotics in the Management of Helicobacter pylori. Cureus 2022; doi: 10.7759/cureus.26463
|
60 |
Nikos Viazis, Konstantinos Argyriou, Katerina Kotzampassi, Dimitrios K. Christodoulou, Periklis Apostolopoulos, Sotirios D. Georgopoulos, Christos Liatsos, Olga Giouleme, Kanellos Koustenis, Christos Veretanos, Dimitris Stogiannou, Miltiadis Moutzoukis, Charalambos Poutakidis, Ioannis Ioardanis Mylonas, Ioulia Tseti, Gerassimos J. Mantzaris. A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates. Nutrients 2022; 14(3): 632 doi: 10.3390/nu14030632
|
61 |
Ana Rita Silva, Maria Alexandra Bernardo, Maria Fernanda Mesquita, José Vaz Patto, Pedro Moreira, Patrícia Padrão, Maria Leonor Silva. Treating Endocrine and Metabolic Disorders With Herbal Medicines. Advances in Medical Diagnosis, Treatment, and Care 2021; : 334 doi: 10.4018/978-1-7998-4808-0.ch015
|
62 |
A. B. Kuznetzova, E. V. Prazdnova, V. A. Chistyakov, O. Yu. Kutsevalova, M. M. Batiushin. Are Probiotics Needed in Nephrology?. Nephrology (Saint-Petersburg) 2022; 26(4): 18 doi: 10.36485/1561-6274-2022-26-4-18-30
|
63 |
Cláudia Sousa, Rute Ferreira, Nuno F. Azevedo, Mónica Oleastro, Joana Azeredo, Ceu Figueiredo, Luís D. R. Melo. Helicobacter pylori infection: from standard to alternative treatment strategies. Critical Reviews in Microbiology 2022; 48(3): 376 doi: 10.1080/1040841X.2021.1975643
|
64 |
Ahmed G. Abdelhamid. Probiotics could pay off in Helicobacter pylori eradication. Drugs & Therapy Perspectives 2020; 36(1): 23 doi: 10.1007/s40267-019-00684-y
|
65 |
Jianfu Ji, Hong Yang. Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy. International Journal of Molecular Sciences 2020; 21(3): 1136 doi: 10.3390/ijms21031136
|
66 |
Kira Kopacz, Sangita Phadtare. Probiotics for the Prevention of Antibiotic-Associated Diarrhea. Healthcare 2022; 10(8): 1450 doi: 10.3390/healthcare10081450
|
67 |
Elena I. Ermolenko, Anastasiya S. Molostova, Natalia V. Baryshnikova, Alena V. Svarval, Nikita S. Gladyshev, Victor A. Kashchenko, Alexander N. Suvorov. The clinical effectiveness of probiotics and autoprobiotics in treatment of <i>Helicobacter pylori</i>-associated dyspepsia. Russian Journal of Infection and Immunity 2022; 12(4): 726 doi: 10.15789/2220-7619-TCE-1927
|
68 |
Shuwei Yang, Jiaqi Qiao, Meng Zhang, Lai-Yu Kwok, Bojana Bogovič Matijašić, Heping Zhang, Wenyi Zhang. Prevention and treatment of antibiotics-associated adverse effects through the use of probiotics: A review. Journal of Advanced Research 2024; doi: 10.1016/j.jare.2024.06.006
|
69 |
Heung Up Kim. Helicobacter pylori Eradication Therapy - Recent Trend in Research. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(3): 210 doi: 10.7704/kjhugr.2019.0051
|
70 |
Skender Telaku, Mimoza Telaku, Emir Behluli, Viktor Isjanovski, Fitim Alidema. Impact of Lactobacillus Reuteri and Three Other Probiotics in Helicobacter Pylori Eradication. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 2215 doi: 10.3889/oamjms.2022.10733
|
71 |
Makan Pourmasoumi, Ameneh Najafgholizadeh, Amir Hadi, Fariborz Mansour-Ghanaei, Farahnaz Joukar. The effect of synbiotics in improving Helicobacter pylori eradication: A systematic review and meta-analysis. Complementary Therapies in Medicine 2019; 43: 36 doi: 10.1016/j.ctim.2019.01.005
|
72 |
Ali Nabavi-Rad, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Abbas Yadegar, Sinéad Marian Smith, Mohammad Reza Zali.
The double-edged sword of probiotic supplementation on gut microbiota structure in
Helicobacter pylori
management
. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2108655
|
73 |
Gaoyan Yao, Xiaoyuan Fan, Dewen Lu. Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of Helicobacter pylori infection: a systematic review and meta-analysis. Journal of International Medical Research 2023; 51(10) doi: 10.1177/03000605231203841
|
74 |
Han-Yi Song, Long Zhou, Dong-yan Liu, Xin-Jie Yao, Yan Li. What Roles Do Probiotics Play in the Eradication of Helicobacter pylori? Current Knowledge and Ongoing Research. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/9379480
|
75 |
Maja Šikić Pogačar, Dušanka Mičetić-Turk, Sabina Fijan. Probiotics in the Prevention and Management of Human Diseases. 2022; : 465 doi: 10.1016/B978-0-12-823733-5.00021-0
|
76 |
M. R. Konorev, E. N. Tyshevich, R. A. Pavlyukov. Application of N-Acetyl-Glucosaminil-N-Acetyl-Muramyl Dipeptide during Triple Component Anti-Helicobacter Pylori Therapy in the Period of Coronavirus Infection COVID-19. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 33(2): 60 doi: 10.22416/1382-4376-2023-33-2-60-69
|